Manganese–gold nanoparticles as an MRI positive contrast agent in mesenchymal stem cell labeling
Source abstract
Abstract
We report a straightforward approach to prepare multifunctional manganese–gold nanoparticles by attaching Mn(II) ions onto the surface of 20 nm citrate-capped gold nanoparticles. In vitro MRI measurements made in agarose gel phantoms exhibited high relaxivity (18.26 ± 1.04 mmol−1 s−1). Controlled incubation of the nanoparticles with mesenchymal stem cells (MSCs) was used to study cellular uptake of these particles and this process appeared to be controlled by the size of the nanoparticle aggregates in the extracellular solution. SEM images of live MSCs showed an increased concentration of particles near the cell membrane and a distribution of the size of particles within the cells. Survivability for MSCs in contact with Mn–Au NPs was greater than 97% over the 3-day period and up to the 1 mM Mn used in this study. The high relaxivity and low cell mortality are suggestive of an enhanced positive contrast agent for in vitro or in vivo applications.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Graphene and Nanomaterials Applications · Nanoplatforms for cancer theranostics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (57)
Show source-provided references
1. Alric C, Taleb J, LeDuc M et al (2008) Gadolinium chelate coated gold nanoparticles as contrast agents for both X-ray and computed tomography and magnetic resonance imaging. J Am Chem Soc 130:5908–591510.1021/ja078176p ↗
2. Au K, Liao S, Lee Y et al (2009) Effects of iron oxide nanoparticles on cardiac differentiation of embryonic stem cells. Biochem Biophys Res Commun 379:898–90310.1016/j.bbrc.2008.12.160 ↗
3. Bae K, Lee K, Kim C, Park T (2011) Surface functionalized hollow manganese oxide nanoparticles for cancer targeted siRNA delivery and magnetic resonance imaging. Biomaterials 32:176–18410.1016/j.biomaterials.2010.09.039 ↗
4. Bataveljić D, Stamenković S, Bačić G et al (2011) Imaging cellular markers of neuroinflammation in the brain of the rat model of amyotrophic lateral sclerosis. Acta Physiol Hung 98:1–510.1556/APhysiol.98.2011.1.1 ↗
5. Bertin A, Steibel J, Michou-Gallani A et al (2009) Development of a dendritic manganese-enhanced magnetic resonance imaging (MEMRI) contrast agent: synthesis, toxicity (in vitro) and relaxivity (in vitro, in vivo) studies. Bioconj Chem 20:760–76710.1021/bc8004683 ↗
6. Bulte J, Zhang S, van Gelderen P et al (1999) Neurotransplantation of magnetically labeled oligodendrocyte progenitors: magnetic resonance tracking of cell migration and myelination. PNAS 96:15256–1526110.1073/pnas.96.26.15256 ↗
7. Carmelli I, Leitus G, Naaman R, Reich S (2003) Magnetism induced by the organization of self-assembled monolayers. J Chem Phys 118:1037210.1063/1.1580800 ↗
8. Cheng H, Kastrup C, Ramanathan R et al (2010) Nanoparticulate cellular patches for cell-mediated tumoritropic delivery. ACS Nano 4:625–63110.1021/nn901319y ↗
9. Chithrani B, Ghazani A, Chan W (2006) Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett 6:662–66810.1021/nl052396o ↗
10. Chuang K, Koretsky A (2006) Improved neuronal tract tracing using manganese enhanced magnetic resonance imaging with fast T(1) mapping. Magn Reson Med 55:604–61110.1002/mrm.20797 ↗
11. Chung J, Yamada M, Yang P (2009) Magnetic resonance imaging of human embryonic stem cells. Curr Protoc Stem Cell Biol. Chapter 5:Unit 5A10.1002/9780470151808.sc05a03s10 ↗
12. Connor E, Mwamuka J, Gole A, Murphy CJ et al (2005) Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small 1:325–32710.1002/smll.200400093 ↗
13. Crespo C, Litran R, Rojas T et al. (2004) Permanent magnetism, magnetic anisotropy, and hysteresis of thiol-capped gold nanoparticles. Phys Rev Lett 93:087204-110.1103/PhysRevLett.93.087204 ↗
14. de la Fuente J, Alcántara D, Eaton P et al (2006) Gold and gold-iron oxide magnetic glyconanoparticles: synthesis, characterization and magnetic properties. J Phys Chem B 110:13021–1302810.1021/jp062522s ↗
15. Du C, MacGowan G, Farkas D, Koretsky AP (2001) Calibration of the calcium dissociation constant of Rhod(2) in the perfused mouse heart using manganese quenching. Cell Calcium 29:217–22710.1054/ceca.2000.0186 ↗
16. Elizondo G, Fretz C, Stark D et al (1991) Preclinical evaluation of MnDPDP: new paramagnetic hepatobiliary contrast agent for MR imaging. Radiology 178:73–7810.1148/radiology.178.1.1898538 ↗
17. Fan J, Hung W, Li W, Yeh J (2009) Biocompatibility study of gold nanoparticles to human cells. In: ICBME 2008, Proceedings, vol 23, pp 870–87310.1007/978-3-540-92841-6_214 ↗
18. Ferreira L, Karp J, Nobre L, Langer R (2008) New opportunities: the use of nanotechnologies to manipulate and track stem cells. Cell Stem Cell 3:136–14610.1016/j.stem.2008.07.020 ↗
19. Frens G (1973) Controlled nucleation for the regulation of the particle size in monodisperse gold suspension. Nat Phys Sci 241:20–2210.1038/physci241020a0 ↗
20. Garitaonandia J, Insausti M, Goikolea E et al (2008) Chemically induced permanent magnetism in Au, Ag, and Cu nanoparticles: localization of the magnetism by element selective techniques. Nano Lett 8:661–66710.1021/nl073129g ↗
21. Gole A, Murphy C (2004) Seed-mediated synthesis of gold nanorods: role of the size and nature of the seed. Chem Mater 16:3633–364010.1021/cm0492336 ↗
22. Hu T, Bao W, Lenhard S et al (2004) Simultaneous assessment of left-ventricular infarction size, function and tissue viability in a murine model of myocardial infarction by cardiac manganese-enhanced magnetic resonance imaging (MEMRI). NMR Biomed 17:620–62610.1002/nbm.933 ↗
23. Hu T, Silva A, Waghorn B et al (2010) Manganese-enhanced magnetic resonance imaging (MEMRI): applications to pre-clinical research. In: Comprehensive Toxicology, 2nd edn, vol 14. Elsevier Press, Amsterdam10.1016/B978-0-08-046884-6.00710-7 ↗
24. Hunyadi Murph S, Serkiz S, Fox E, et al (2011a) Synthesis, functionalization, characterization and application of controlled shape nanoparticles in energy production, American Chemical Society, Book Chapter, Symposium Series Volume, vol 1064, Chapter 8, 2011, pp 127–16310.1021/bk-2011-1064.ch008 ↗
25. Hunyadi Murph SE, Murphy CJ, Colon-Mercado HR, Torres RD, Heroux KJ et al (2011b) Tuning of size and shape of Au-Pt nanocatalysts for direct methanol fuel cells. J Nanopart Res 13(12):6347–636410.1007/s11051-011-0449-1 ↗
26. Hunyadi S, Murphy C (2006) Bimetallic silver–gold nanowires: fabrication and use in surface-enhanced Raman scattering. J Mater Chem 16:3929–393510.1039/B607116C ↗
27. Idee J, Port M, Medina C et al (2008) Possible involvement of gadolinium chelates in the pathophysiology of nephrogenic systemic fibrosis: a critical review. Toxicology 248:77–8810.1016/j.tox.2008.03.012 ↗
28. Kim Y, Johnson R, Hupp JT (2001) Gold nanoparticle-based sensing of “spectroscopically silent” heavy metal ions. Nano Lett 1:165–16710.1021/nl0100116 ↗
29. Kosutra L, Kraitchman D, Mackay A et al (2004) Feridex labeling of mesenchymal stem cells inhibits chondrogenesis but not adipogenesis or osteogenesis. NMR Biomed 17:513–51710.1002/nbm.925 ↗
30. Loening A, Gambhir S (2003) AMIDE: a free software tool for the multimodality medical imaging analysis. Mol Imaging 2:131–13710.1162/153535003322556877 ↗
31. MacGowan G, Evans C, Hu T et al (2004) Troponin I protein kinase C phosphorylation sites and ventricular function. Cardiovasc Res 63:245–25510.1016/j.cardiores.2004.04.010 ↗
32. Mahmood M, Casciano D, Mocan T et al (2010) Cytotoxicity and biological effects of functional nanomaterials delivered to various cell lines. J Appl Toxicol 30:74–8310.1002/jat.1475 ↗
33. Martell A, Smith R (1974) Critical stability constants Arthur E. Martell and Robert M. Smith Plenum Press, New York
34. Mertzman J, Kar S, Lofland S et al (2009) Surface attached manganese–oxo clusters as potential contrast agents. Chem Commun 8:788–79010.1039/b815424d ↗
35. Murphy C, Sau T, Gole A et al (2005) Anisotropic metal nanoparticles: synthesis, assembly, and optical applications. J Phys Chem B 109:13857–1387010.1021/jp0516846 ↗
36. Murphy C, Gole A, Hunyadi S et al (2006) One-dimensional colloidal gold and silver nanostructures. Inorg Chem 45:7544–755410.1021/ic0519382 ↗
37. Murphy C, Gole A, Hunyadi S et al (2008) Chemical sensing and imaging with metallic nanorods. Chem Commun 4:554–557
38. Na H, Lee J, An K et al (2007) Development of a T1 contrast agent for magnetic resonance imaging using MnO nanoparticles. Angew Chem 46:5397–540110.1002/anie.200604775 ↗
39. Nagel E, Al-Saadi N, Fleck E (2000) Cardiovascular magnetic resonance: myocardial perfusion. Hertz 25(4):409–416
40. O’Neal D, Hirsch L, Halas N et al (2004) Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles. Cancer Lett 209:171–17610.1016/j.canlet.2004.02.004 ↗
41. Oszlánczi G, Vezér T, Sárközi L et al (2010) Functional neurotoxicity of Mn-containing nanoparticles in rats. Ecotoxicol Environ Saf 73:2005–200910.1016/j.ecoenv.2010.09.002 ↗
42. Piera P, Radler J (2009) The defined presentation of nanoparticles to cells and their surface controlled uptake. Biomaterials 30:3766–377010.1016/j.biomaterials.2009.03.031 ↗
43. Pillai Z, Kamat P (2004) Control the size and shape of silver nanoparticles in the citrate ion reduction method. J Phys Chem B 108:945–95110.1021/jp037018r ↗
44. Popovtzer R, Agrawal A, Kotov N et al (2008) Targeted gold nanoparticles enable molecular CT imaging of cancer. Nanoletters 8:4593–459610.1021/nl8029114 ↗
45. Prockop D (1997) Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276:71–7410.1126/science.276.5309.71 ↗
46. Skjold A, Amundsen B, Wiseth R et al (2007) Manganese dipyridoxyl-diphosphate (MnDPDP) as a viability marker in patients with myocardial infarction. J Magn Reson Imaging 26:720–72710.1002/jmri.21065 ↗
47. Spaeth E, Klopp A, Dembinski J et al (2008) Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells. Gene Ther 15:730–73810.1038/gt.2008.39 ↗
48. Strijkers G, Mulder W, van Tilborg G et al (2007) MRI contrast agents: current status and future perspectives. Anticancer Agents Med Chem 7:291–30510.2174/187152007780618135 ↗
49. Tanaka K, Sata M (2008) Contribution of circulating vascular progenitors in lesion formation and vascular healing: lessons from animal models. Curr Opin Lipidol 19:498–50410.1097/MOL.0b013e32830dd566 ↗
50. Taylor M, Reither WJ, Lin W (2008) Manganese-based nanoscale metal-organic frameworks for magnetic resonance imaging. J Am Chem Soc 130:14358–1435910.1021/ja803777x ↗
51. Unrine J, Bertsch P, Hunyadi S (2008) In: Vicki Grassian (ed) Nanoscience and Nanotechnology: Environmental and Health Impacts, Wiley, New York, pp 343–364
52. Waghorn B, Edwards T, Yang Y et al (2008) Monitoring dynamic alterations in calcium homeostasis by T(1)-weighted and T(1)-mapping cardiac manganese-enhanced MRI in a murine myocardial infarction model. NMR Biomed 21:1102–111110.1002/nbm.1287 ↗
53. Waghorn B, Schumacher A, Liu J, Jacobs S et al (2011) Indirectly probing Ca(2+) handling alterations following myocardial infarction in a murine model using T(1)-mapping manganese-enhanced magnetic resonance imaging. Magn Reson Med 65:239–24910.1002/mrm.22597 ↗
54. Warsi M, Adams R, Duckett S, Chechik V (2010) Gd-functionalised Au nanoparticles as targeted contrast agents in MRI: relaxivity enhancement by polyelectrolyte coating. Chem Commun (Camb) 21:451–45310.1039/B915223G ↗
55. Westbrook C, Roth C, Talbot J (2005) MRI in Practice, 3rd edn. Blackwell, Oxford
56. Wisner E, Merisko-Liversidge E, Kellar K et al (1995) Preclinical evaluation of manganese carbonate particles for magnetic resonance imaging of the liver. Acad Radiol 2:140–14710.1016/S1076-6332(05)80149-7 ↗
57. Zhang S, Li J, Lykotrafitis G et al (2009) Size-dependent endocytosis of nanoparticles. Adv Mater 21:419–42410.1002/adma.200801393 ↗